In addition, we analyzed FGFR3 mRNA expression in NSCLC patients using the MethHC database (http://methhc.mbc.nctu.edu.tw/php/index.php) [28], and the results indicated that mRNA expression of FGFR3 in tumor (T) was escalated, compared with that in normal (N) samples (Figure 1(e)). This evidence concerns the gene FGFR3 and non-small cell lung carcinoma.